We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy 5 Stocks at 52-Week High With More Upside for the Short Term
Read MoreHide Full Article
Key Takeaways
ACEL's earnings growth outlook and brokerage targets point to up to 41.3% upside potential.
ASUR's workforce solutions business supports 21.9% expected earnings growth and 42% upside potential.
BTSG, CLMB and CHE benefit from growth drivers, with up to 31.8%, 20.3% and 23.5% upside.
Any stock at its 52-week high may indicate strong positive momentum in the company's underlying fundamentals, such as increasing earnings or revenue growth. This can be a sign of a healthy and growing business, which could translate into potential price appreciation.
Moreover, stocks trading at their 52-week high may also be indicative of positive investor sentiment and market confidence in the company. This can result in increased demand for the stock, driving up its price.
However, it is important to note that investing solely based on a stock's 52-week high is not a foolproof strategy. Investors should consider using 52 week highs in conjunction with other fundamental and technical analysis.
Here, we recommend five stocks with a favorable Zacks Rank that are currently trading around their 52-week highs. Additionally, these stocks have double-digit price upside potential in the short term.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Accel Entertainment Inc.
Zacks Rank #2 (Buy) Accel Entertainment is a distributed gaming operator primarily in the United States. ACEL’s business consists of the installation, maintenance and operation of video gaming terminals, redemption devices that disburse winnings and contain ATM functionality, as well as other amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops and grocery stores.
Accel Entertainment has an expected revenue and earnings growth rate of 9.2% and 26.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 10.1% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 17.9% from the last closing price of $13.45. The brokerage target price is currently in the range of $13-$19. This indicates a maximum upside of 41.3% and a downside of 3.3%.
Asure Software Inc.
Zacks Rank #2 Asure Software is a provider of Web-based workforce management solutions. ASUR offers web-based workforce management solutions that enable organizations to manage their office environment, as well as their human resource and payroll processes.
ASUR offers its workforce management solutions under two product lines: NetSimplicity and iEmployee. ASUR’s suite includes products to optimize workforce time and attendance tracking, benefits enrollment and tracking, pay stubs and W2 documentation, expense management, meeting and event management, and asset tracking.
Asure Software has an expected revenue and earnings growth rate of 16% and 21.9%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.5% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 26.2% from the last closing price of $10.56. The brokerage target price is currently in the range of $11-$15. This indicates a maximum upside of 42% and a downside of 4.2%.
BrightSpring Health Services Inc.
BrightSpring Health’s integrated pharmacy and provider platform benefits from the shift of complex care toward lower-cost home and community settings. Specialty and Infusion growth is supported by broader access to limited-distribution therapies, new launches and manufacturer partnerships.
BTSG’s rising home-health volumes, acquired branches and preferred payor relationships extend Provider Services reach. Coordinated care and high quality ratings support referrals and patient retention.
BrightSpring Health has an expected revenue and earnings growth rate of 23.5% and 91%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.2% over the last seven days.
Zacks Rank #1 Climb Global Solutions operates as a value-added IT distribution and solutions company in the United States, Canada, Europe, and the United Kingdom. CLMB operates through two segments, Distribution and Solutions.
CLMB distributes technical software to corporate and value-added resellers, consultants, and systems integrators under the name Climb Channel Solutions, and provides cloud solutions and resells software, hardware, and services under the name Grey Matter. CLMB also resells computer software and hardware developed by others, as well as provides technical services to end-user customers.
Climb Global Solutions has an expected revenue and earnings growth rate of 20.7% and 7.1%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 14.7% from the last closing price of $41.58. The brokerage target price is currently in the range of $46-$50. This indicates a maximum upside of 20.3% and no downside.
Chemed Corp.
Zacks Rank #2 Chemed’s outlook remains balanced as VITAS sustains patient growth and Roto-Rooter expands its service footprint. Higher hospice admissions, a favorable referral mix and reduced Medicare Cap exposure support VITAS revenue and margins.
Roto-Rooter is benefiting from commercial sales initiatives, better water-restoration collections and franchise acquisitions. CHE’s cash generation and revolving credit capacity support capital deployment.
Chemed has an expected revenue and earnings growth rate of 8% and 19.6%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.3% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 12.8% from the last closing price of $546.75. The brokerage target price is currently in the range of $580-$675. This indicates a maximum upside of 23.5% and no downside.
Image: Shutterstock
Buy 5 Stocks at 52-Week High With More Upside for the Short Term
Key Takeaways
Any stock at its 52-week high may indicate strong positive momentum in the company's underlying fundamentals, such as increasing earnings or revenue growth. This can be a sign of a healthy and growing business, which could translate into potential price appreciation.
Moreover, stocks trading at their 52-week high may also be indicative of positive investor sentiment and market confidence in the company. This can result in increased demand for the stock, driving up its price.
However, it is important to note that investing solely based on a stock's 52-week high is not a foolproof strategy. Investors should consider using 52 week highs in conjunction with other fundamental and technical analysis.
Here, we recommend five stocks with a favorable Zacks Rank that are currently trading around their 52-week highs. Additionally, these stocks have double-digit price upside potential in the short term.
These stocks are: Accel Entertainment Inc. (ACEL - Free Report) , Asure Software Inc. (ASUR - Free Report) , BrightSpring Health Services Inc. (BTSG - Free Report) , Climb Global Solutions Inc. (CLMB - Free Report) and Chemed Corp. (CHE - Free Report) .
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Accel Entertainment Inc.
Zacks Rank #2 (Buy) Accel Entertainment is a distributed gaming operator primarily in the United States. ACEL’s business consists of the installation, maintenance and operation of video gaming terminals, redemption devices that disburse winnings and contain ATM functionality, as well as other amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops and grocery stores.
Accel Entertainment has an expected revenue and earnings growth rate of 9.2% and 26.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 10.1% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 17.9% from the last closing price of $13.45. The brokerage target price is currently in the range of $13-$19. This indicates a maximum upside of 41.3% and a downside of 3.3%.
Asure Software Inc.
Zacks Rank #2 Asure Software is a provider of Web-based workforce management solutions. ASUR offers web-based workforce management solutions that enable organizations to manage their office environment, as well as their human resource and payroll processes.
ASUR offers its workforce management solutions under two product lines: NetSimplicity and iEmployee. ASUR’s suite includes products to optimize workforce time and attendance tracking, benefits enrollment and tracking, pay stubs and W2 documentation, expense management, meeting and event management, and asset tracking.
Asure Software has an expected revenue and earnings growth rate of 16% and 21.9%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.5% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 26.2% from the last closing price of $10.56. The brokerage target price is currently in the range of $11-$15. This indicates a maximum upside of 42% and a downside of 4.2%.
BrightSpring Health Services Inc.
BrightSpring Health’s integrated pharmacy and provider platform benefits from the shift of complex care toward lower-cost home and community settings. Specialty and Infusion growth is supported by broader access to limited-distribution therapies, new launches and manufacturer partnerships.
BTSG’s rising home-health volumes, acquired branches and preferred payor relationships extend Provider Services reach. Coordinated care and high quality ratings support referrals and patient retention.
BrightSpring Health has an expected revenue and earnings growth rate of 23.5% and 91%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.2% over the last seven days.
The short-term average price target of brokerage firms represents an increase of 18.3% from the last closing price of $69.83. The brokerage target price is currently in the range of $70-$92. This indicates a maximum upside of 31.8% and no downside for this Zacks Rank #1 (Strong Buy) stock. You can see the complete list of today’s Zacks #1 Rank stocks here.
Climb Global Solutions Inc.
Zacks Rank #1 Climb Global Solutions operates as a value-added IT distribution and solutions company in the United States, Canada, Europe, and the United Kingdom. CLMB operates through two segments, Distribution and Solutions.
CLMB distributes technical software to corporate and value-added resellers, consultants, and systems integrators under the name Climb Channel Solutions, and provides cloud solutions and resells software, hardware, and services under the name Grey Matter. CLMB also resells computer software and hardware developed by others, as well as provides technical services to end-user customers.
Climb Global Solutions has an expected revenue and earnings growth rate of 20.7% and 7.1%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 14.7% from the last closing price of $41.58. The brokerage target price is currently in the range of $46-$50. This indicates a maximum upside of 20.3% and no downside.
Chemed Corp.
Zacks Rank #2 Chemed’s outlook remains balanced as VITAS sustains patient growth and Roto-Rooter expands its service footprint. Higher hospice admissions, a favorable referral mix and reduced Medicare Cap exposure support VITAS revenue and margins.
Roto-Rooter is benefiting from commercial sales initiatives, better water-restoration collections and franchise acquisitions. CHE’s cash generation and revolving credit capacity support capital deployment.
Chemed has an expected revenue and earnings growth rate of 8% and 19.6%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.3% over the last 30 days.
The short-term average price target of brokerage firms represents an increase of 12.8% from the last closing price of $546.75. The brokerage target price is currently in the range of $580-$675. This indicates a maximum upside of 23.5% and no downside.